| http://www.w3.org/ns/prov#value | - Consequently, PPAR?? agonists may prove valuable in treating and/or preventing restenosis. [0008] Troglitazone, and other thiazolidinediones, are novel insulin-sensitizing agents that significantly reduce hyper-insulinemia and hyper-glycemia (Law, R. E. et al. 1993.
|
